3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioblastoma
45
Neuroblastoma
16
Glioma
16
Brain Neoplasms
14
Astrocytoma
10
Neoplasms
8
Rhabdomyosarcoma
7
Sarcoma, Ewing
6
Recurrence
5
Oligodendroglioma
5
Medulloblastoma
5
Sarcoma
4
Osteosarcoma
4
Melanoma
4
Small Cell Lung Carcinoma
3
Neuroendocrine Tumors
3
Neuroectodermal Tumors, Primitive
3
Lymphoma
3
Gliosarcoma
3
Diffuse Intrinsic Pontine Glioma
3
Wilms Tumor
2
Rhabdoid Tumor
2
Pyloric Stenosis, Hypertrophic
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Ganglioneuroblastoma
2
Fallopian Tube Neoplasms
2
Ependymoma
2
Colorectal Neoplasms
2
Central Nervous System Neoplasms
2
Interventions
Medical Marijuana
2
nabiximols
1
Temozolomide
1
Dronabinol
1
Cannabidiol
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Marijuana Abuse
×
Temozolomide
×
Clear all
NCT05629702
2026-05-05
ARISTOCRAT
University of Birmingham
Phase 2
Recruiting
120 enrolled